SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-265842
Filing Date
2019-10-10
Accepted
2019-10-10 16:16:06
Documents
3
Period of Report
2019-10-04
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d815828d8k.htm 8-K 21597
2 EX-10.1 d815828dex101.htm EX-10.1 17054
3 GRAPHIC g815828g1010192501384.jpg GRAPHIC 3743
  Complete submission text file 0001193125-19-265842.txt   45220
Mailing Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380
Business Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380 484-453-3300
Verrica Pharmaceuticals Inc. (Filer) CIK: 0001660334 (see all company filings)

IRS No.: 463137900 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38529 | Film No.: 191146326
SIC: 2834 Pharmaceutical Preparations